Piper Sandler raised the firm's price target on Ormat Technologies to $90 from $78 and keeps a Neutral rating on the shares. Shares are up 33% year to date as the improving regulatory environment and
As previously reported, Piper Sandler initiated coverage of Janux Therapeutics with an Overweight rating and $42 price target. While noting that investor sentiment has waned over the course of 2025 fo
Piper Sandler analyst Kelsey Goodwin last night initiated coverage of Revolution Medicines with an Overweight rating and $75 price target. The firm believes the stock's value will be driven by confide
Piper Sandler initiated coverage of Day One Biopharmaceuticals with an Overweight rating and $25 price target. Piper thinks the stock move following the first two 2025 earnings reports is overdone and
As previously reported, Piper Sandler initiated coverage of UroGen Pharma with an Overweight rating and $36 price target. Investors are starting to gain more confidence in the Zusduri launch, but the
Piper Sandler analyst Kelsey Goodwin initiated coverage of CG Oncology with an Overweight rating and $55 price target. The stock currently reflects low uptake in the initial high-risk Bacillus Calmett
MINNEAPOLIS--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the hiring of Toby AuWerter as a managing director in the merchant banking group.
Piper Sandler's Q2 results were solid in advisory and great in brokerage and muni financing. The brokerage activity is fully expected to moderate in Q3 due to lower volatility. Deal volumes are fallin
Piper Sandler Companies (PIPR) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, PIPR's 50-day simple moving average crossed ab
Piper Sandler Companies (PIPR) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term
Piper Sandler Companies (NYSE:PIPR ) Q2 2025 Earnings Conference Call August 1, 2025 8:00 AM ET Company Participants Chad R. Abraham - Chairman, CEO & Head of Financial Services Debbra Lynn Schoneman
Piper Sandler Companies (PIPR) came out with quarterly earnings of $2.95 per share, beating the Zacks Consensus Estimate of $1.99 per share. This compares to earnings of $2.52 per share a year ago.
MINNEAPOLIS--(BUSINESS WIRE)---- $PIPR--The complete earnings release can be found on the firm's website at pipersandler.com/earnings.
MINNEAPOLIS--(BUSINESS WIRE)---- $PIPR--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, announced today that it has entered into a definitive agreement to acquire G Squared Capital Pa
MINNEAPOLIS--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Anson Tsai as a managing director to its technology investment ban
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE